A US-based multinational pharma company is embedding sustainability in its operations in an effort to advance global health by reducing the carbon footprints.
In the financial year 2023, the company’s proactive energy and emission reduction initiatives achieved remarkable outcomes cutting back nearly 28 million kilowatt-hours of annual energy usage and reducing around 7,300 metric tons of carbon dioxide equivalent emissions. These actions are a testament to its commitment to fostering health on a global scale without compromising environmental stewardship.
Complementing these efforts, the company prioritized renewable energy sources by purchasing over 260 million kilowatt-hours of low-carbon and renewable energy in 2023, resulting in approximately 64,000 metric tons of carbon dioxide equivalent emissions avoided. Additionally in financial year 2023, solar installations at 13 locations generated around 3.9 million kilowatt-hours of energy, further decreasing dependency on non-renewable resources and supporting its environmental goals.
Through these substantial achievements, the company reaffirms its dedication to building a sustainable future. Its approach seamlessly integrates sustainability into every aspect of its operations from innovation in healthcare technology to responsible resource management setting a high standard for environmentally conscious practices in the industry.
Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
